|
| 36063397 | Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022). | Clin Infect Dis | 2024 |
| 37112972 | HIV-1 Group M Capsid Amino Acid Variability: Implications for Sequence Quality Control of Genotypic Resistance Testing. | Viruses | 2023 |
| 37766338 | Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review. | | 2023 |
| 37738247 | Recommendations on data sharing in HIV drug resistance research. | PLoS Med | 2023 |
| 37801004 | Human immunodeficiency virus 1 5'-leader mutations in plasma viruses before and after the development of reverse transcriptase inhibitor-resistance mutations. | | 2023 |
| 36908615 | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic. | | 2023 |
| 36515174 | Highly Ambiguous HIV-1 Pol Positions Encoding Multiple Amino Acids Usually Result from Antiviral or Immune Selection Pressure. | AIDS Res Hum Retroviruses | 2023 |
| 37333388 | HIV-1 5'-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance Mutations. | | 2023 |
| 36642087 | Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study. | Lancet HIV | 2023 |
| 36750835 | Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance. | | 2023 |
| 35325204 | Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike Function. | Mol Biol Evol | 2022 |
| 36375130 | 2022 update of the drug resistance mutations in HIV-1. | Top Antivir Med | 2022 |
| 36102816 | Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells. | Clinical Microbiology Reviews | 2022 |
| 35510849 | A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT). | Microbiology spectrum | 2022 |
| 35700134 | Susceptibility of SARS-CoV-2 Omicron Variants to Therapeutic Monoclonal Antibodies: Systematic Review and Meta-analysis. | Microbiol Spectr | 2022 |
| 35631067 | Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations. | Pathogens | 2022 |
| 36334368 | Sierra SARS-CoV-2 sequence and antiviral resistance analysis program. | Journal of Clinical Virology | 2022 |
| 35544100 | Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review. | Lancet Microbe, The | 2022 |
| 36191692 | Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir. | Antiviral Res | 2022 |
| 36680108 | Insights into HIV-1 Transmission Dynamics Using Routinely Collected Data in the Mid-Atlantic United States. | Viruses | 2022 |
| 35075456 | Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike function. | bioRxiv | 2022 |
| 35263335 | Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons. | PLoS ONE | 2022 |
| 35157724 | Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system. | PLoS One | 2022 |
| 34535792 | The biological and clinical significance of emerging SARS-CoV-2 variants. | Nature Reviews Genetics | 2021 |
| 34296992 | SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA. | Emerging Infectious Diseases | 2021 |
| 34064774 | Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance. | Viruses | 2021 |
| 33683148 | Integrase Strand Transfer Inhibitor Resistance in Integrase Strand Transfer Inhibitor-Naive Persons. | AIDS Research and Human Retroviruses | 2021 |
| 34319150 | SARS-CoV-2 Antiviral Therapy. | Clinical Microbiology Reviews | 2021 |
| 32974670 | In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations. | Journal of Antimicrobial Chemotherapy | 2021 |
| 34787497 | SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021. | Microbiology spectrum | 2021 |
| 33409413 | A SARS-CoV-2 antiviral therapy score card. | | 2020 |
| 31965175 | Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2. | J Infect Dis | 2020 |
| 31774913 | Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I. | Journal of Infectious Diseases | 2020 |
| 31617907 | Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance. | Journal of Antimicrobial Chemotherapy | 2020 |
| 32102090 | Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences. | PLoS One | 2020 |
| 32490370 | Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women. | EClinicalMedicine | 2020 |
| 32936523 | HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates. | J Int AIDS Soc | 2020 |
| 33143751 | Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria. | AIDS Research and Therapy | 2020 |
| 32916958 | Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds. | Viruses | 2020 |
| 32575676 | Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing. | Viruses | 2020 |
| 32516949 | Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations. | Viruses | 2020 |
| 32904894 | Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens. | Open Forum Infect Dis | 2020 |
| 31317771 | Amino Acid Prevalence of HIV-1 Mutations by Direct Polymerase Chain Reaction and Single Genome Sequencing. | AIDS Research and Human Retroviruses | 2019 |
| 31634862 | 2019 update of the drug resistance mutations in HIV-1. | Top Antivir Med | 2019 |
| 30430843 | Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa. | AIDS Research and Human Retroviruses | 2019 |
| 30052811 | Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel. | Clin Infect Dis | 2019 |
| 30520997 | Reply to Ambrosioni et al. | Clin Infect Dis | 2019 |
| 30321316 | The Clinical Implications of Pretreatment Drug Resistance-A Moving Target. | Clinical Infectious Diseases | 2019 |
| 29846534 | Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population. | Clin Infect Dis | 2019 |
| 31143879 | Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis. | eClinicalMedicine | 2019 |